Literature DB >> 10460100

The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.

R S Klein1, T Flanigan, P Schuman, D Smith, D Vlahov.   

Abstract

SETTING: A collaborative study in four urban medical centers in the United States.
OBJECTIVE: To determine the effect of human immunodeficiency virus (HIV) infection and immunodeficiency on delayed type hypersensitivity (DTH) responses and the implications for interpretation of tuberculin reactions in non-anergic women with or at risk for HIV infection.
DESIGN: Demographic and behavioral information, HIV antibody testing, CD4+ lymphocyte counts, and cutaneous responses to DTH testing with mumps, Candida, tetanus toxoid, and tuberculin (purified protein derivative-PPD) antigens were obtained in 1184 women.
RESULTS: Reactions to one or more of the four antigens occurred in 436 HIV-seropositive and 356 high-risk seronegative women. Among non-anergic women, HIV-seropositives were less likely (P < or = 0.05) to react to mumps (62% vs 81%), tetanus (72% vs 84%), and PPD (13% vs 19%). Induration in HIV-seropositive reactors was associated with CD4+ cell level for mumps (P = 0.004) and tetanus (P < 0.001), but not for Candida or PPD. HIV-seropositive reactors with CD4+ cell counts >500/mm3 did not have significantly smaller reactions than HIV-seronegatives for any antigen tested. PPD sizes were similar among HIV-seropositive reactors with CD4+ cell counts >500/mm3 (12.4 +/- 7.4 mm) and HIV-seronegative reactors (12.0 +/- 8.3 mm); induration > or =10 mm was seen in 16/173 (9.2%) seropositive women with CD4+ cell counts >500/mm3 and 41/356 (11.5%) seronegative women, respectively (P = 0.5).
CONCLUSION: Among HIV-infected women able to react to a DTH antigen, induration in response to that antigen was relatively intact at CD4+ counts >500/mm3. This suggests that degree of immunodeficiency should be considered when interpreting PPD reactions in HIV-infected persons.

Entities:  

Mesh:

Year:  1999        PMID: 10460100

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

Review 1.  Tuberculin test.

Authors:  V K Chadha
Journal:  Indian J Pediatr       Date:  2001-01       Impact factor: 1.967

Review 2.  Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons.

Authors:  Christopher Akolo; Florence Bada; Evaezi Okpokoro; Ogochukwu Nwanne; Sharon Iziduh; Eno Usoroh; Taofeekat Ali; Vivian Ibeziako; Olanrewaju Oladimeji; Michael Odo
Journal:  World J Virol       Date:  2015-05-12

Review 3.  Human brain derived cell culture models of HIV-1 infection.

Authors:  P Seth; E O Major
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

4.  Spectrum of primary immunodeficiency disorders in Sri Lanka.

Authors:  Nilhan Rajiva de Silva; Sepali Gunawardena; Damayanthi Rathnayake; Geethani Devika Wickramasingha
Journal:  Allergy Asthma Clin Immunol       Date:  2013-12-27       Impact factor: 3.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.